JPRN-UMIN000032362已完成未知
Investigator initiated clinical trial for tracheal reconstruction in patients with severe tracheal stenosis to confirm the safety and efficacy of the tissue-engineered tracheal cartilage using autologous cells - The clinial trial of tissue-engineered trachea composed of cartilage and mucosal epithelium
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who meet any of the following criteria are excluded. 1. Patients from whom sufficient blood cannot be collected (e.g. by recent blood donation). 2. ASA physical status 3 or worse. 3. Existing or possible malignancy. 4. Uncontrolled diabetes. 5. Possible sepsis. 6. Recurrent skin infection at the surgical sites, e.g. ears or trachea. 7. Patients who received, or will undergo surgeries at the operative sites within 1 year before surgery in this trial. 8. Females with existing or possible pregnancy, lactating, or who cannot agree with anticonception until 6 months after the transplantation of TKY2016. 9. Patients found positive in allergy test for atelocollagen 10. Possible syphilis, B/C hepatitis, HIV infection or adult T cell lymphoma. 11. Present, past or family histories of autoimmune diseases, e.g. rheumatoid arthritis, psoriatic arthritis, systemic/discoid lupus erythematosus, dermatomyositis, polymyositis, chronic thyroiditis, Graves' disease, polyartritis, scleroderma, ulcerous colitis, Crohn's disease, Sjogren's syndrome, Reiter syndrome, mixed connective tissue disease or relapsing polychondritis. 12. Histories of anaphylaxia. 13. Histories or possibilities of hypersensitivity or allergy to collagen products, lactic and glycolic acid polymer, fibroblast growth factor (FGF), insulin, penicillin or streptomycin. 14. Patients who used or will use FGF-2, parathyroid hormone, insulin-like growth factor-I, insulin, growth hormone, female hormones (except cosmetics), male hormones, interleukin-1 receptor antagonist, thyroid hormone, vitamin D (except supplements) or steroids (except topical products) 3 months before blood collection. 15. Patients who were in other clinical trials or clinical researches within 30 days before the obtainment of the consent. 16. Patients with mental diseases who cannot fill out survey slips. 17. Patients judged to be inappropriate as subjects of this trial by the responsive doctor or assigned doctors.
研究者
相似试验
已完成
不适用
Investigator initiated clinical study on the efficacy and safety of autologous cultured chondrocyte processed product (IK-01) in patients with focal articular cartilage lesion in the kneeJPRN-UMIN000008171Ryosuke Kuroda, M.D., Ph.D10
尚未招募
不适用
A randomized control trial investigating the effectiveness of three different upper jaw expansion devices in correcting narrow upper jaws in 10-16 year old children.Constricted MaxillaACTRN12617001136392Sydney Dental Hospital60
已完成
不适用
A randomized clinical trial of the tracheal tube with subglottic secretion drainage for preventing ventilator-associated pneumonia (VAP).ventilator-associated pneumonia (VAP)JPRN-UMIN000003371Chiba hokuso hospital,Nippon medical school240
已完成
不适用
A randomised controlled trial of early versus standard Speech Pathology review and intervention: tracheostomy patients in intensive careCommunication in tracheostomy patients in intensive carePhysical Medicine / Rehabilitation - Speech therapyRespiratory - Other respiratory disorders / diseasesACTRN12610000075088Royal Prince Alfred Hosptial30
已完成
不适用
A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH)COPD and sPAHJPRN-UMIN000002080Tohoku University20